BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Oct 04, 2010
 |  BC Week In Review  |  Clinical News  |  Regulatory

Viread tenofovir disoproxil fumarate regulatory update

Gilead received a warning letter from FDA related to violations of cGMP regulations identified during an inspection of the company's San Dimas, Calif. manufacturing facility earlier this year. The letter includes deficiencies in the manufacturing of its antifungal drug AmBisome liposomal amphotericin B, including control systems...

Read the full 219 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >